参考文献/References:
[1] Brennan MA,Cookson BT.Salmonella induces macrophage death by caspase-1-dependent necrosis[J].Mol Microbiol,2000,38(1):31-40.DOI:10.1046/j.1365-2958.2000.02103.x.
[2] Galluzzi L,Vitale I,Aaronson SA,et al.Molecular mechanisms of cell death:recommendations of the Nomenclature Committee on Cell Death 2018[J].Cell Death Differ,2018,25(3):486-541.DOI:10.1038/s41418-017-0012-4.
[3] Sangiuliano B,Pérez NM,Moreira DF,et al.Cell death-associated molecular-pattern molecules:inflammatory signaling and control[J].Mediators Inflamm,2014,2014:821043.DOI:10.1155/2014/821043.
[4] 董娜,邵峰.细胞焦亡的机制和功能[J].中国科学(生命科学),2019,49(12):1606-1634.DOI:10.1360/SSV-2019-0242.
[5] Li X,Zeng L,Cao C,et al.Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy[J].Exp Cell Res,2017,350(2):327-335.DOI:10.1016/j.yexcr.2016.12.006.
[6] Fu Y,Wu N,Zhao D.Function of NLRP3 in the pathogenesis and development of diabetic nephropathy[J].Med Sci Monit,2017,23:3878-3884.DOI:10.12659/msm.903269.
[7] Shahzad K,Bock F,Al-Dabet MM,et al.Caspase-1,but not caspase-3,promotes diabetic nephropathy[J].J Am Soc Nephrol,2016,27(8):2270-2275.DOI:10.1681/ASN.2015060676.
[8] Yeh WJ,Yang HY,Pai MH,et al.Long-term administration of advanced glycation end-product stimulates the activation of NLRP3 inflammasome and sparking the development of renal injury[J].J Nutr Biochem,2017,39:68-76.DOI:10.1016/j.jnutbio.2016.09.014.
[9] Chang YP,Ka SM,Hsu WH,et al.Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy[J].J Cell Physiol,2015,230(7):1567-1579.DOI:10.1002/jcp.24903.
[10] Wang Y,Zhang H,Chen Q,et al.TNF-α/HMGB1 inflammation signalling pathway regulates pyroptosis during liver failure and acute kidney injury[J].Cell Prolif,2020,53(6):e12829.DOI:10.1111/cpr.12829.
[11] Zhou R,Tardivel A,Thorens B,et al.Thioredoxin-interacting protein links oxidative stress to inflammasome activation[J].Nat Immunol,2010,11(2):136-140.DOI:10.1038/ni.1831.
[12] Feng H,Gu J,Gou F,et al.High glucose and lipopolysaccharide prime NLRP3 inflammasome via ROS/TXNIP pathway in mesangial cells[J].J Diabetes Re,2016,2016:6973175.DOI:10.1155/2016/6973175.
[13] He Y,Hara H,Nú ez G.Mechanism and regulation of NLRP3 in ammasome activation[J].Trends Biochem Sci,2016,41(12):1012-1021.DOI:10.1016/j.tibs.2016.09.002.
[14] Yi H,Peng R,Zhang LY,et al.LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy[J].Cell Death Dis,2017,8(2):e2583.DOI:10.1038/cddis.2016.451.
[15] Samra YA,Said HS,Elsherbiny NM,et al.Cepharanthine and piperine ameliorate diabetic nephropathy in rats:role of NF-κB and NLRP3 inflammasome[J].Life Sci,2016,157:187-199.DOI:10.1016/j.lfs.2016.06.002.
[16] Du L,Wang J,Chen Y,et al.Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy[J].Cell Biol Toxicol,2020,36(3):243-260.DOI:10.1007/s10565-019-09501-8.
[17] Zhou X,Liu Z,Ying K,et al.WJ-39,an aldose reductase inhibitor,ameliorates renal lesions in diabetic nephropathy by activating Nrf2 signaling[J].Oxid Med Cell Longev,2020,2020:7950457.DOI:10.1155/2020/7950457.
[18] Song S,Qiu D,Luo F,et al.Knockdown of NLRP3 alleviates high glucose or TGFB1-induced EMT in human renal tubular cells[J].J Mol Endocrinol,2018,61(3):101-113.DOI:10.1530/JME-18-0069.
[19] Wang S,Zhao X,Yang S,et al.Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway[J].Chem Biol Interact,2017,278:48-53.DOI:10.1016/j.cbi.2017.10.012.
[20] Lu M,Yin N,Liu W,et al.Curcumin ameliorates diabetic nephropathy by suppressing NLRP3 inflammasome signaling[J].Biomed Res Int,2017,2017:1516985.DOI:10.1155/2017/1516985.
[21] Dai Y,Dai D,Wang X,et al.DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1beta via GLP-1 receptor in macrophages through protein kinase C pathway[J].Cardiovasc Drugs Ther,2014,28(5):425-432.DOI:10.1007/s10557-014-6539-4.
[22] 蒲阅丽,刘淬平,徐勇,等.恩格列净通过抑制细胞焦亡改善糖尿病小鼠肾脏损伤[J].中华内分泌代谢杂志,2021,37(02):149-155.DOI:10.3760/cma.j.cn311282-20200528-00392.
相似文献/References:
[1]李雅,王志斌,刘玮晔,等.巨噬细胞与糖尿病肾病[J].国际内分泌代谢杂志,2014,(06):393.[doi:10.3760/cma.j.issn.1673-4157.2014.06.009]
Li Ya*,Wang Zhibin,Liu Weiye,et al.Macrophages and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2014,(02):393.[doi:10.3760/cma.j.issn.1673-4157.2014.06.009]
[2]王丹,关美萍,薛耀明.早期生长反应因子-1与糖尿病肾病[J].国际内分泌代谢杂志,2014,(06):397.[doi:10.3760/cma.j.issn.1673-4157.2014.06.010]
Wang Dan,Guan Meiping,Xue Yaoming..Early growth response factor-1 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2014,(02):397.[doi:10.3760/cma.j.issn.1673-4157.2014.06.010]
[3]翟丽敏,叶山东.二甲双胍的抗炎作用及其糖尿病肾脏保护作用[J].国际内分泌代谢杂志,2014,(05):334.[doi:10.3760/cma.j.issn.1673-4157.2014.05.013]
Zhai Limin,Ye Shandong..Anti-inflammatory effects of metformin and its renal protection in diabetes[J].International Journal of Endocrinology and Metabolism,2014,(02):334.[doi:10.3760/cma.j.issn.1673-4157.2014.05.013]
[4]玄先法,李清芹,王玉新,等.肾炎康复片联合缬沙坦治疗Ⅳ期糖尿病肾病蛋白尿的临床研究[J].国际内分泌代谢杂志,2014,(05):353.[doi:10.3760/cma.j.issn.1673-4157.2014.05.019]
Xuan Xianfa,Li Qingqin,Wang Yuxin,et al.Clinical study of Shenyankangfu tablet combined with valsartan capsule on proteinuria in patients with stage Ⅳ diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2014,(02):353.[doi:10.3760/cma.j.issn.1673-4157.2014.05.019]
[5]曹萌 陈堃 茅晓东 刘超.限食治疗糖尿病肾病的研究进展[J].国际内分泌代谢杂志,2015,(06):395.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.009]
Cao Meng,Chen Kun,Mao Xiaodong,et al.Effects of diet restriction on diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(02):395.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.009]
[6]于菁 王秋月.多聚ADP核糖聚合酶-1与糖尿病肾病[J].国际内分泌代谢杂志,2015,(06):409.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.013]
Yu Jing,Wang Qiuyue..Poly(ADP-ribose)polymerase-1 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(02):409.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.013]
[7]马静茹,牟新.表观遗传学与糖尿病肾病[J].国际内分泌代谢杂志,2016,36(01):52.[doi:10.3760/cma.j.issn.1673-4157.2016.01.013]
Ma Jingru*,Mou Xin..Epigenetics and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2016,36(02):52.[doi:10.3760/cma.j.issn.1673-4157.2016.01.013]
[8]杨薇,李春君,孙蓓,等.雷公藤多苷对糖尿病肾病大鼠核因子-κB
信号通路的影响[J].国际内分泌代谢杂志,2016,36(02):107.[doi:10.3760/cma.j.issn.1673-4157.2016.02.008]
Yang Wei*,Li Chunjun,Sun Bei,et al.Effects of triperygium wilfordii polyglucoside on nuclear factor-κB signaling pathway in rats with diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2016,36(02):107.[doi:10.3760/cma.j.issn.1673-4157.2016.02.008]
[9]刘艳,田秀标,韩颖,等.血管紧张素1-7与糖尿病及糖尿病肾脏
内质网应激关系的研究[J].国际内分泌代谢杂志,2016,36(03):157.[doi:10.3760/cma.j.issn.1673-4157.2016.03.04]
Liu Yan*,Tian Xiubiao,Han Ying,et al.Relationship between angiotensin 1-7, diabetes and endoplasmic reticulum stress of diabetic kidney[J].International Journal of Endocrinology and Metabolism,2016,36(02):157.[doi:10.3760/cma.j.issn.1673-4157.2016.03.04]
[10]周宇,柯甦捷,刘礼斌.血尿酸与糖尿病肾病[J].国际内分泌代谢杂志,2016,36(03):202.[doi:10.3760/cma.j.issn.1673-4157.2016.03.15]
Zhou Yu,Ke Sujie,Liu Libin..Serum uric acid and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2016,36(02):202.[doi:10.3760/cma.j.issn.1673-4157.2016.03.15]